Treatment of Recurrent Thymoma
Thymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma. The treatment methods include reoperation, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In th...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2020-03-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.11 |
| _version_ | 1818305561531252736 |
|---|---|
| author | Xianping LIU Xiao LI Jianfeng LI |
| author_facet | Xianping LIU Xiao LI Jianfeng LI |
| author_sort | Xianping LIU |
| collection | DOAJ |
| description | Thymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma. The treatment methods include reoperation, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In this article, we review the previous literature and summarize the indications, efficacy and prognosis of different treatments for recurrent thymoma, so as to provide some reference for treatment criteria for recurrent thymoma. |
| first_indexed | 2024-12-13T06:28:33Z |
| format | Article |
| id | doaj.art-cddbdabfd5b6474c8e3217749b77dc17 |
| institution | Directory Open Access Journal |
| issn | 1009-3419 1999-6187 |
| language | zho |
| last_indexed | 2024-12-13T06:28:33Z |
| publishDate | 2020-03-01 |
| publisher | Chinese Anti-Cancer Association; Chinese Antituberculosis Association |
| record_format | Article |
| series | Chinese Journal of Lung Cancer |
| spelling | doaj.art-cddbdabfd5b6474c8e3217749b77dc172022-12-21T23:56:40ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872020-03-0123320421010.3779/j.issn.1009-3419.2020.03.11Treatment of Recurrent ThymomaXianping LIU0Xiao LI1Jianfeng LI2Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, ChinaDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, ChinaDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, ChinaThymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma. The treatment methods include reoperation, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In this article, we review the previous literature and summarize the indications, efficacy and prognosis of different treatments for recurrent thymoma, so as to provide some reference for treatment criteria for recurrent thymoma.http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.11recurrent thymomasurgical treatmentchemotherapyradiotherapytargeted therapy |
| spellingShingle | Xianping LIU Xiao LI Jianfeng LI Treatment of Recurrent Thymoma Chinese Journal of Lung Cancer recurrent thymoma surgical treatment chemotherapy radiotherapy targeted therapy |
| title | Treatment of Recurrent Thymoma |
| title_full | Treatment of Recurrent Thymoma |
| title_fullStr | Treatment of Recurrent Thymoma |
| title_full_unstemmed | Treatment of Recurrent Thymoma |
| title_short | Treatment of Recurrent Thymoma |
| title_sort | treatment of recurrent thymoma |
| topic | recurrent thymoma surgical treatment chemotherapy radiotherapy targeted therapy |
| url | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.11 |
| work_keys_str_mv | AT xianpingliu treatmentofrecurrentthymoma AT xiaoli treatmentofrecurrentthymoma AT jianfengli treatmentofrecurrentthymoma |